PLASMODIUM VIVAX INFECTION
Clinical trials for PLASMODIUM VIVAX INFECTION explained in plain language.
Never miss a new study
Get alerted when new PLASMODIUM VIVAX INFECTION trials appear
Sign up with your email to follow new studies for PLASMODIUM VIVAX INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New malaria vaccine trial aims to stop parasite in its tracks
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine (PvRII/Matrix-M) to see if it is safe and can slow down the malaria parasite in the blood. About 36 healthy Thai adults aged 20-55 will take part; half get the vaccine and half get a placebo. After three doses, some volunteers will be exposed to the…
Matched conditions: PLASMODIUM VIVAX INFECTION
Phase: PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:37 UTC
-
Promising malaria vaccine trial aims to block p. vivax infection
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests an experimental vaccine called PvCS/Montanide ISA-51 to see if it can safely prevent malaria caused by the P. vivax parasite. 72 healthy adults aged 18-50 will receive three shots of the vaccine or a placebo, then be exposed to infected mosquitoes under medical s…
Matched conditions: PLASMODIUM VIVAX INFECTION
Phase: PHASE2 • Sponsor: Malaria Vaccine and Drug Development Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:27 UTC